SPOTLIGHT: JAMA editor scolds Pfizer for subpoenas

The Journal of the American Medical Association lambasted Pfizer for threatening the "integrity" of its peer-review-based decision-making system by subpoenaing peer reviews for its Celebrex and Bextra defense. After posting that editorial on JAMA's website, editor Catherine DeAngelis told the WSJ Health Blog that a medical journal "may as well pack it up and go home" if it gave drugmakers the kind of information Pfizer wanted. Report

Suggested Articles

The cleaning procedures are so poor at a Zydus Cadila plant in India that the FDA says a sampling found 10 different cross-contaminated products.

Oklahoma politicians contend J&J should be on the line for future abatement costs even after a $572 million verdict, but J&J sees things differently.

Abbott helmsman Miles White, who oversaw the spinoffs of AbbVie and Hospira, will step down as CEO after 21 years at the top job.